Project Grant RF1NS132920
Award Date
9/20/24
Completion Date
8/31/27
Dollars Obligated
$2.1M
Federal Agency
National Institute of Neurological Disorders and Stroke
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Indianapolis, IN 46202, USA
Similar Awards
This federal Project Grant award, provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Drug Use and Addiction Research Programs (CFDA 93.279), is focused on developing novel methods for selectively stimulating nociceptors (pain receptors) and measuring the brain's nociceptive-specific response in both healthy individuals and those with the chronic pain condition fibromyalgia. The $2,314,276 award to Emory University will fund the creation of a new...
This federal Project Grant award of $668,131 was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to Washington University in Missouri. The award is funding a research project titled "Mesolimbic Adaptations Underlying Altered Reward Sensitivity in Neuropathic Pain" with the goal of understanding the relationship between chronic neuropathic pain and altered dopaminergic function in the brain's reward system. The...
The federal Project Grant award titled "State-Dependent Control of Nociception in Opioid Circuits" is funded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The $667,349 grant aims to investigate the neurobiological mechanisms underlying pain perception and modulation, with a focus on endogenous opioid signaling in the ventrolateral periaqueductal gray...
This federal Project Grant award of $146,922 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) is funding research to evaluate the association between general chronic pain liability and clinically recognized substance use. The project aims to estimate the effect of chronic pain on substance use, accounting for heterogeneity across and comorbidity among chronic pain conditions. The research will also support the awardee, the Trustees...
This $233,088 federal Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) is supporting research at Washington University to investigate the role of endogenous opioids in the dorsal raphe nucleus (DRN) in regulating motivational and affective behaviors during chronic pain. The primary goal is to use dual-color 1-photon endoscopic imaging to examine how enkephalin neuron activity in the DRN modulates the emotional and motivational...
This $664,772 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) supports research to investigate a novel, non-opioid spinal analgesic mechanism for the treatment of high impact chronic pain. The primary awardee, the University of Texas Southwestern Medical Center, will evaluate the signaling pathway involving the neurotensin receptor 2 (NTSR2) and...
This Project Grant award of $222,758.00, provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to disentangle the specific contributions of different dorsal root ganglia (DRG) neuron types to pain representation in the brain. The project will utilize a novel chemogenetic tool to selectively inhibit distinct classes of DRG neurons and assess their role in various types of pain. It will also...
This $2,569,851 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Drug Abuse and Addiction Research Programs (CFDA 93.279), supports research to investigate how the PD-L1/PD-1 immune checkpoint pathway controls physiological and pathological pain, as well as opioid analgesia, through neuronal, immune, and glial mechanisms. The project aims to validate the actions of PD-L1 and the checkpoint inhibitor nivolumab on neuroinflammation and...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $246,750 to The Trustees of Columbia University in the City of New York, Health Sciences Division, to research the role of the mesocortical glutamatergic pathway in the development and maintenance of chronic neuropathic pain. The project aims to use in vivo imaging,...
This $239,052 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) supports research to characterize orexinergic projections from the hypothalamus to the spinal cord and examine their role in chronic pain transmission. The research aims to apply two-photon calcium imaging to probe the functional consequences of orexin peptide treatment on spinal...